Alert detail
LCD L40278: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer — WPS
What changed
WPS final LCD on non-NGS molecular panel tests for cancer therapy—eff. 10/12/26
Who’s affected: Oncology billing teams · Effective: October 12, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.